BridgeMD
New treatment option for Myocardial Infarction (MI)
Official title The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
ClinicalTrials.gov ID: NCT07027891
What this study is testing
- What it's testing
- This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- chest pain
- suspicious of acute myocardial infarction
You likely can't join if
- STEMI
- Revisit of same symptoms within 1 week
- traumatic chest pain
- Pneumothorax
- Transferred from other hospital diagnosed of AMI
- Cardiac arrest
See the full eligibility criteria
- chest pain
- suspicious of acute myocardial infarction
- STEMI
- Revisit of same symptoms within 1 week
- traumatic chest pain
- Pneumothorax
- Transferred from other hospital diagnosed of AMI
- Cardiac arrest
- Chest pain of clearly non-cardiac etiology
- declined to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.